全文获取类型
收费全文 | 3242621篇 |
免费 | 257206篇 |
国内免费 | 7563篇 |
专业分类
耳鼻咽喉 | 45767篇 |
儿科学 | 102107篇 |
妇产科学 | 87327篇 |
基础医学 | 463522篇 |
口腔科学 | 93172篇 |
临床医学 | 305867篇 |
内科学 | 624110篇 |
皮肤病学 | 65230篇 |
神经病学 | 272795篇 |
特种医学 | 126111篇 |
外国民族医学 | 1129篇 |
外科学 | 474573篇 |
综合类 | 76800篇 |
现状与发展 | 2篇 |
一般理论 | 1381篇 |
预防医学 | 272006篇 |
眼科学 | 75487篇 |
药学 | 242412篇 |
12篇 | |
中国医学 | 6538篇 |
肿瘤学 | 171042篇 |
出版年
2018年 | 35176篇 |
2017年 | 26902篇 |
2016年 | 29399篇 |
2015年 | 33462篇 |
2014年 | 47517篇 |
2013年 | 73162篇 |
2012年 | 99368篇 |
2011年 | 105083篇 |
2010年 | 61593篇 |
2009年 | 58141篇 |
2008年 | 98418篇 |
2007年 | 104683篇 |
2006年 | 105468篇 |
2005年 | 102476篇 |
2004年 | 98116篇 |
2003年 | 94352篇 |
2002年 | 92491篇 |
2001年 | 145181篇 |
2000年 | 150022篇 |
1999年 | 126980篇 |
1998年 | 37577篇 |
1997年 | 34049篇 |
1996年 | 33467篇 |
1995年 | 32374篇 |
1994年 | 30339篇 |
1993年 | 28400篇 |
1992年 | 102648篇 |
1991年 | 99703篇 |
1990年 | 96610篇 |
1989年 | 92655篇 |
1988年 | 86075篇 |
1987年 | 84648篇 |
1986年 | 80509篇 |
1985年 | 76958篇 |
1984年 | 58568篇 |
1983年 | 49956篇 |
1982年 | 30473篇 |
1981年 | 27124篇 |
1979年 | 54585篇 |
1978年 | 38654篇 |
1977年 | 32316篇 |
1976年 | 30801篇 |
1975年 | 32256篇 |
1974年 | 39615篇 |
1973年 | 38131篇 |
1972年 | 35559篇 |
1971年 | 32989篇 |
1970年 | 30841篇 |
1969年 | 28532篇 |
1968年 | 26390篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
991.
Abstract Migraine without aura is typically considered a female condition. The purpose of this study was to determine if there have
been any changes in the female-to-male ratio of the disease over time. We included in the study all patients with migraine
without aura (n=3457) referred to the Parma University Headache Centre between 1976 and 1995. They were divided into subgroups with respect
to gender and year-range of onset of migraine (before 1960, in the 1960s, in the 1970s, in the 1980s, and between 1990 and
1995). Gender ratio ranged from 3.6:1 (in patients with onset before 1960) to 2.8:1 (in patients with onset in the 1980s),
with no statistically significant changes during the observation period. 相似文献
992.
Social phobia, fear of negative evaluation and harm avoidance. 总被引:1,自引:0,他引:1
M Faytout J Tignol J Swendsen D Grabot B Aouizerate J P Lépine 《European psychiatry》2007,22(2):75-79
This naturalistic, prospective investigation examined the role of fear of negative evaluation and the personality trait of harm avoidance in the anxiety levels of treated social phobia patients. One hundred and fifty-seven patients with DSM-IV social phobia were assessed before starting treatment and were then followed for up to two years. As expected, greater fear of negative evaluation and higher scores of harm avoidance were associated with greater anxiety at the 6 month follow-up, and harm avoidance remained a significant predictor at 24 months. However, no evidence was found for an interaction between the personality and cognitive variables examined. The findings are discussed in terms of the relative independence of these factors, as well as their potential implications for the treatment of this disorder. 相似文献
993.
994.
妊娠性肝内胆汁淤积症(ICP)的主要特征是:母体难以忍受的瘙痒症,血清胆汁酸升高(≥10μmol/L)以及胎儿死亡风险的增加。最近,确定了一个与影响胎儿损害相关的界值,即血清胆汁酸≥40μmol/L。在一项双盲、安慰剂对照试验中,作研究了熊脱氧胆酸(UDCA)和地塞米松对瘙痒症、胆汁淤积的生化指标和胎儿并发症发生率的影响。为此,选取了130例患有ICP的妇女,随机分到UDCA组(1g/d,使用3周),地塞米松组(12mg/d使用1周,第2周、第3周使用安慰剂)和安慰剂组(使用3周)进行治疗。在治疗期间和治疗3周后对瘙痒症和胆汁淤积的生化指标进行分析。在分娩时记录胎儿的并发症(自发性早产,新生儿窒息,羊水、胎盘、胎膜的胎粪染色)。意向治疗分析显示仅在UDCA组中,丙氨酸转氨酶(ALT)(P=0.01)和胆红素(P=0.002)明显减少。在血清胆汁酸≥40μmol/L的ICP妇女的亚群分析中发现(n=34)UDCA对瘙痒症(减轻75%)、胆汁酸(下降79%)、ALT(降低80%)和胆红素(降低50%)也有明显效果,但对胎儿并发症发生率无影响。地塞米松并无减轻瘙痒症或降低ALT的作用,在降低胆汁酸和胆红素方面比UDCA效果差。 相似文献
995.
Kelboek H Thuesen L Helqvist S 《世界核心医学期刊文摘》2006,2(5):53-54
目的:SCANDSTENT试验旨在评价西罗莫司洗脱支架(SES)在复杂冠状动脉病变中的应用。背景:与裸金属支架(BMS)相比,在简单冠状动脉病变中使用SES能够改善造影和临.床的结果,但是,有关在复杂病变中使用SES的安全性和有效性的证据有限。方法:322例有症状的复杂冠状动脉疾病患者被随机分配接受SES或BMS治疗。病变形态分别为全闭(36%)、分叉(34%)、开口(22%)或成角(8%)改变。主要终点为支架置入6个月后血管最小管腔直径的差别。 相似文献
996.
997.
Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation 总被引:2,自引:0,他引:2
Rolf N. Barth Christina A. Janus Christine A. Lillesand Nancy A. Radke John D. Pirsch Bryan N. Becker Luis A. Fernandez L. Thomas Chin Yolanda T. Becker Jon S. Odorico Anthony M. D''Alessandro Hans W. Sollinger Stuart J. Knechtle 《Transplant international》2006,19(11):885-892
Campath-1H (alemtuzumab) induction was used for renal transplantation in combination with sirolimus as immunosuppression. We previously reported a high (28%) rate of early rejection with this regimen, and now report 3-year outcomes. Twenty-nine patients were recipients of either deceased donor or non-HLA (Human Leukocyte Antigen) identical living donor primary renal allografts. Clinical parameters including infection, malignancy, kidney function, and kidney histology were followed prospectively for 3 years. Three-year cumulative graft and patient survival were 96% and 100%, respectively. Twenty patients were maintained on steroid-free immunosuppressive regimens, and 15 patients were maintained on monotherapy for immunosuppression (12 on sirolimus). No serious infectious complications were observed and two patients developed basal cell skin cancer. The 3-year results of our initial pilot study demonstrate good graft (96%) and patient (100%) outcomes. Campath-1H induction has yielded a high proportion of patients maintained on immunosuppressive monotherapy (57%) without serious infectious- and no malignancy-related complications. The reported regimen yielded novel insights into both Campath-1H and sirolimus therapy in renal transplantation. Because of the higher incidence of early rejection, we recommend a modified strategy of immunosuppression including a brief course of a calcineurin inhibitor. 相似文献
998.
J Masata A Martan K Svabik P Drahoradova M Pavlikova 《Ultrasound in obstetrics & gynecology》2006,28(2):221-228
OBJECTIVES: To evaluate changes in the mobility of the whole urethra, in the proximal urethra (funneling) and in the thickness of the urinary bladder wall, after a successful tension-free vaginal tape (TVT) procedure. METHODS: This prospective longitudinal study included 52 women with urodynamically confirmed stress urinary incontinence who had undergone a successful TVT procedure. Ultrasound examination was performed before the TVT procedure and at a median of 3 (range, 3-6) months after surgery. For all women, the changes to the urethra and urinary bladder induced by surgery were examined. For three mobility groups (low, intermediate and high urethral mobility before surgery) we compared the changes induced by the operation and the typical position and mobility of the tape. RESULTS: The position of the urethra at rest was not influenced by surgery. The operation significantly decreased the mobility of all parts of the urethra during Valsalva. The absolute changes of the vector of the urethral movement differed according to the mobility group (average decrease, 6 mm; decrease for women with low, intermediate and high mobility, respectively, 2-3 mm, 4-6 mm and 9 mm). The change in relative mobility was the same in all groups. The operation decreased funneling (width and depth) during maximal Valsalva. After surgery there was an increase in the thickness of the bladder wall (by 0.64 and 0.73 mm, respectively, at the anterior part and trigone). CONCLUSIONS: A successful TVT procedure did not influence the position of the urethra at rest but significantly decreased the mobility of the urethra during Valsalva and also decreased funneling at maximal Valsalva. 相似文献
999.
1000.
M B?ttner J Christoffel G Rimoldi W Wuttke 《Experimental and clinical endocrinology & diabetes》2006,114(2):82-90
The lack of estrogen during menopause is associated with various symptoms including osteoporosis, cardiovascular diseases, and menopausal symptoms. For many years, conventional hormone replacement therapy has been successfully used to treat these conditions. However, in light of recent studies that draw attention to potential hazards of conventional HRT, various attempts were undertaken to search for alternatives of classical HRT. Phytoestrogens are supposed to ameliorate various discomforts associated with menopause. Resveratrol (RES) is present in red wine, grapes and peanuts and has been implicated in cardioprotection and prevention of adverse side effects observed after regular HRT. As the pituitary-thyroid axis is a target of estrogen action, we first assessed the effects of E2 administration on thyroid hormone stimulating hormone releasing hormone (TRH)-induced thyroid stimulating hormone (TSH) secretion from pituitary cell cultures in vitro. Our data reveal that E2 treatment augments the TRH-induced TSH secretion. We furthermore designed a long-term study of three months to assess the effects of subcutaneous and oral administration of 17beta-estradiol (E2), as well as the actions of RES on the pituitary-thyroid axis in ovariectomized (OVX) female rats. Our results demonstrate that serum levels of 1.0 and 8.1 microM RES lead to a significant increase in total serum triiodthyronine (T3) levels. OVX induces TSHbeta mRNA in the adenohypohysis and E2 treatment attenuates this effect. Treatment of rats with subcutaneous implants of E2 does not affect the pituitary-thyroid axis, whereas orally applied E2 benzoate (E2B) increases plasma TSH and total thyroxine (T4) in OVX rats. In all animals, we could not detect changes in thyroid morphology as assessed by hematoxylin-eosin (HE) and Perjod-Acid Schiff's (PAS) staining. 相似文献